Osimertinib for NSCLC With Uncommon EGFR Mutations
IsraelSuspended
Conditions
Carcinoma, Non-Small-Cell Lung · Genes, erbB-1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sheba Medical Centre, Ramat Gan, Israel
Study leads
Jair Bar, MD-PhD
Principal Investigator
Sheba Medical Center, Ramat Gan, Israel
Alfredo Addeo, MD
Principal Investigator
University Hospital, Geneva